4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-024105
Chief Scientific Officer sold 3,000 shares at an average $67.71 ($203,135)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2019-04-05 | Option exercise | +3,000 | $39.76 | $119,280 | 29,511 | D |
| Biller Scott Chief Scientific Officer | 2019-04-05 | Sale | −2,401 | $67.61 | $162,332 | 27,110 | D |
| Biller Scott Chief Scientific Officer | 2019-04-05 | Sale | −599 | $68.12 | $40,804 | 26,511 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2019-04-05 | Option exercise · Stock option (right to buy) | −3,000 | 39,648 | D | ||
| Open-market sales · 3,000 sh · avg $67.71 · $203,135 | |||||||
Loading xslF345X03/doc4.xml…